| Dec 16, 2025 |
Dec 19, 2025 |
4D Molecular Therapeutics, Inc.
|
Chief Legal Officer |
Sell |
13.8
|
-1,635
|
-31.27%
|
✓
|
$17.8K |
| Nov 17, 2025 |
Nov 19, 2025 |
4D Molecular Therapeutics, Inc.
|
Chief Legal Officer |
Sell |
13.8
|
-1,635
|
-31.27%
|
✓
|
$17.3K |
| Oct 24, 2025 |
Oct 27, 2025 |
4D Molecular Therapeutics, Inc.
|
Chief Legal Officer |
Sell |
13.8
|
-2,678
|
-42.70%
|
✓
|
$32.1K |
| Oct 16, 2025 |
Oct 20, 2025 |
4D Molecular Therapeutics, Inc.
|
Chief Legal Officer |
Sell |
18.8
|
-1,635
|
-23.96%
|
✓
|
$16.6K |
| Oct 9, 2025 |
Oct 14, 2025 |
4D Molecular Therapeutics, Inc.
|
Chief Legal Officer |
Sell |
13.8
|
-2,408
|
-31.70%
|
✓
|
$24.1K |
| Sep 23, 2025 |
Sep 26, 2025 |
4D Molecular Therapeutics, Inc.
|
Chief Legal Officer |
Sell |
18.8
|
-2,407
|
-24.06%
|
✓
|
$19.3K |
| Sep 16, 2024 |
Sep 18, 2024 |
4D Molecular Therapeutics, Inc.
|
Chief Legal Officer |
Sell |
37.5
|
-500
|
-6.87%
|
✓
|
$8.2K |
| Aug 19, 2024 |
Aug 21, 2024 |
4D Molecular Therapeutics, Inc.
|
Chief Legal Officer |
Sell |
37.5
|
-500
|
-6.87%
|
✓
|
$7.5K |
| Jul 16, 2024 |
Jul 18, 2024 |
4D Molecular Therapeutics, Inc.
|
Chief Legal Officer |
Sell |
18.8
|
-1,750
|
-20.51%
|
✓
|
$47.4K |
| Jul 11, 2024 |
Jul 15, 2024 |
4D Molecular Therapeutics, Inc.
|
Chief Legal Officer |
Sell |
18.8
|
-1,996
|
-22.74%
|
✓
|
$49.9K |
| Jul 1, 2024 |
Jul 3, 2024 |
4D Molecular Therapeutics, Inc.
|
Chief Legal Officer |
Sell |
10.0
|
-4,248
|
-70.98%
|
✓
|
$90.8K |
| Jun 17, 2024 |
Jun 20, 2024 |
4D Molecular Therapeutics, Inc.
|
Chief Legal Officer |
Sell |
13.8
|
-1,750
|
-50.19%
|
✓
|
$41.5K |
| May 16, 2024 |
May 20, 2024 |
4D Molecular Therapeutics, Inc.
|
Chief Legal Officer |
Sell |
13.8
|
-1,750
|
-50.19%
|
✓
|
$44.5K |
| Apr 16, 2024 |
Apr 18, 2024 |
4D Molecular Therapeutics, Inc.
|
Chief Legal Officer |
Sell |
13.8
|
-1,750
|
-50.19%
|
✓
|
$45K |
| Apr 1, 2024 |
Apr 3, 2024 |
4D Molecular Therapeutics, Inc.
|
Chief Legal Officer |
Sell |
7.5
|
-8,153
|
-82.44%
|
✓
|
$259.1K |
| Mar 27, 2024 |
Mar 29, 2024 |
4D Molecular Therapeutics, Inc.
|
Chief Legal Officer |
Sell |
10.0
|
-5,833
|
-77.05%
|
✓
|
$204.4K |
| Mar 18, 2024 |
Mar 20, 2024 |
4D Molecular Therapeutics, Inc.
|
Chief Legal Officer |
Sell |
10.0
|
-1,750
|
-50.19%
|
✓
|
$54.7K |
| Feb 27, 2024 |
Feb 29, 2024 |
4D Molecular Therapeutics, Inc.
|
Chief Legal Officer |
Sell |
10.0
|
-1,909
|
-52.36%
|
✓
|
$57.3K |
| Feb 16, 2024 |
Feb 21, 2024 |
4D Molecular Therapeutics, Inc.
|
Chief Legal Officer |
Sell |
13.8
|
-1,750
|
-50.19%
|
✓
|
$48.4K |
| Feb 8, 2024 |
Feb 12, 2024 |
4D Molecular Therapeutics, Inc.
|
Chief Legal Officer |
Sell |
10.0
|
-6,244
|
-54.51%
|
✓
|
$171.7K |
| Jun 8, 2023 |
Jun 12, 2023 |
4D Molecular Therapeutics, Inc.
|
Chief Legal and HR Officer |
Sell |
10.0
|
-3,750
|
-68.34%
|
✓
|
$78.2K |
| Jun 1, 2023 |
Jun 6, 2023 |
4D Molecular Therapeutics, Inc.
|
Chief Legal and HR Officer |
Sell |
13.8
|
-2,247
|
-56.40%
|
✓
|
$41.1K |
| Apr 21, 2023 |
Apr 25, 2023 |
4D Molecular Therapeutics, Inc.
|
Chief Legal and HR Officer |
Sell |
10.0
|
-3,750
|
-64.00%
|
✓
|
$75K |
| Mar 1, 2023 |
Mar 3, 2023 |
4D Molecular Therapeutics, Inc.
|
Chief Legal and HR Officer |
Sell |
13.8
|
-2,248
|
-51.60%
|
✓
|
$43.4K |
| Dec 1, 2022 |
Dec 5, 2022 |
4D Molecular Therapeutics, Inc.
|
Chief Legal and HR Officer |
Sell |
20.0
|
-6,000
|
-16.41%
|
✓
|
$136.7K |